Results
20,720 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Setia VishwasChief Financial Officer |  MPLTMapLight Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $60K 2,068 sh | May 6, 2026 traded May 6, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $60K 2,068 sh | May 6, 2026 traded May 6, 2026 | |
Foff Erin PennockChief Medical Officer |
| MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan |
| SELL |
| $21K 700 sh |
| May 6, 2026 traded May 4, 2026 |
| 16 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 683 sh | May 6, 2026 traded May 4, 2026 |
| 16 |  April McClain DelaneyDDependent child |  MORNMorningstar, Inc.Partial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 30, 2026 |
| 16 | Cline Christopher R.CHIEF FINANCIAL OFFICER |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $102K 2,181 sh | May 6, 2026 traded May 5, 2026 |
| 16 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $229K 8,152 sh | May 6, 2026 traded May 6, 2026 |
| 16 | April McClain DelaneyDDependent child | MORNMorningstar, Inc. Partial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 16, 2026 |
| 16 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $9,607 325 sh | May 6, 2026 traded May 4, 2026 |
| 16 | April McClain DelaneyDDependent child | MORNMorningstar, Inc. Partial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 17, 2026 |
| 16 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $238K 8,496 sh | May 6, 2026 traded May 6, 2026 |
| 16 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $24K 787 sh | May 6, 2026 traded May 4, 2026 |
| 16 | April McClain DelaneyDDependent child |  VIKViking Holdings LtdPartial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 16, 2026 |
| 16 | April McClain DelaneyDDependent child |  BROBROWN & BROWN, INC.Partial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 17, 2026 |
| 16 | April McClain DelaneyDDependent child |  FBINFortune Brands Innovations, Inc.Partial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 24, 2026 |
| 16 | April McClain DelaneyDDependent child | VIKViking Holdings Ltd Partial sale | SELL | $1,001 – $15K | May 6, 2026 traded Apr 20, 2026 |
| 14 | Watanabe ToddDirector, See Remarks |  ARQTArcutis Biotherapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $75K 3,172 sh | May 6, 2026 traded May 4, 2026 |
| 14 | Porter James RichardDirector, President and CEO |  NUVLNuvalent, Inc.Open-market sale · 10b5-1 plan | SELL | $1.77M 17.4K sh | May 6, 2026 traded May 4, 2026 |
| 13 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $14K 310 sh | May 6, 2026 traded May 6, 2026 |
| 13 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $14K 311 sh | May 6, 2026 traded May 6, 2026 |
| 13 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $28K 968 sh | May 6, 2026 traded May 5, 2026 |
| 13 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 931 sh | May 6, 2026 traded May 5, 2026 |
| 12 | Schlachet AmirDirector, CEO |  GLBEGlobal-E Online Ltd.Open-market sale · 10b5-1 plan | SELL | $299K 9,450 sh | May 6, 2026 traded May 5, 2026 |
| 11 | Vairavan LathaSVP Chief Financial Officer | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $32K 1,341 sh | May 6, 2026 traded May 4, 2026 |
| 11 | Matsuda MasaruSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 884 sh | May 6, 2026 traded May 4, 2026 |
| 11 | Holleran KevinDirector, President and CEO |  HAYWHayward Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $764K 52.4K sh | May 6, 2026 traded May 5, 2026 |
| 9 | Ong Chin YinChief Org Capability Officer |  GRABGrab Holdings LtdOpen-market sale · 10b5-1 plan | SELL | $136K 38.0K sh | May 6, 2026 traded May 4, 2026 |
| 8 | Liu CurtisDirector, Chief Technology Officer, 10% Owner |  AMPLAmplitude, Inc.Open-market sale · 10b5-1 plan | SELL | $143K 17.6K sh | May 6, 2026 traded May 4, 2026 |
| 7 | Porter James RichardDirector, President and CEO | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $754K 7,429 sh | May 6, 2026 traded May 4, 2026 |
| 5 | Fordenwalt Matthew W.SVP Lifecycle Services |  ROKROCKWELL AUTOMATION, INCOpen-market sale · 10b5-1 plan | SELL | $207K 460 sh | May 6, 2026 traded May 5, 2026 |
| 4 | Porter James RichardDirector, President and CEO | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $217K 2,111 sh | May 6, 2026 traded May 4, 2026 |
| 4 | Porter James RichardDirector, President and CEO | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $140K 1,408 sh | May 6, 2026 traded May 4, 2026 |
| 4 | Porter James RichardDirector, President and CEO | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $167K 1,699 sh | May 6, 2026 traded May 4, 2026 |
| 3 | Yi StevenDirector, See Remarks |  MAXMediaAlpha, Inc.Open-market sale · 10b5-1 plan | SELL | $36K 4,000 sh | May 6, 2026 traded May 4, 2026 |
| 3 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 4,000 sh | May 6, 2026 traded May 6, 2026 |
| 3 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $36K 4,000 sh | May 6, 2026 traded May 5, 2026 |
| 1 | Ruddy Marcella K.Chief Medical Officer |  TECXTectonic Therapeutic, Inc.Open-market sale · 10b5-1 plan | SELL | $32K 1,065 sh | May 6, 2026 traded May 4, 2026 |
| 1 | Fordenwalt Matthew W.SVP Lifecycle Services | ROKROCKWELL AUTOMATION, INC Open-market sale · 10b5-1 plan | SELL | $63K 140 sh | May 6, 2026 traded May 5, 2026 |
| 1 | Howe James F.President, Motion |  GPCGENUINE PARTS COOpen-market sale · 10b5-1 plan | SELL | $43K 415 sh | May 6, 2026 traded May 5, 2026 |
| 56 | Da Cunha Gustavo WerneckCEO and Board Member |  GGBGERDAU S.A.Open-market sale | SELL | $396K 88.0K sh | May 5, 2026 traded Apr 28, 2026 |
| 41 | Southerton DawnPrincipal Accounting Officer |  JBLUJETBLUE AIRWAYS CORPOpen-market sale | SELL | $91K 18.2K sh | May 5, 2026 traded May 4, 2026 |